Drug Profile
NK 109
Alternative Names: BenzophenanthridiniumLatest Information Update: 21 Aug 2007
Price :
$50
*
At a glance
- Originator Nippon Kayaku
- Class Antineoplastics; Antiplatelets; Benzophenanthridines; Small molecules
- Mechanism of Action Platelet activating factor inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Thrombosis